Patents Assigned to HARROW IP, LLC
  • Ocular lubricant formulations
    Patent number: 11918603
    Abstract: Provided herein are formulations and compositions for ocular diseases or disorders such as dry eye disease. Further provided herein are methods for manufacturing ocular formulations and compositions.
    Type: Grant
    Filed: August 27, 2019
    Date of Patent: March 5, 2024
    Assignee: Harrow IP, LLC
    Inventors: William Stringer, Michael Hanrahan, Patrick H. Witham
  • Adrenocorticotropic hormone-based pharmaceutical formulations and methods for fabricating and using thereof
    Patent number: 11534481
    Abstract: Pharmaceutical compositions for treating, mitigating or preventing autoimmune diseases and associated conditions are described herein. Methods for fabricating the compositions and using them are also described.
    Type: Grant
    Filed: January 28, 2020
    Date of Patent: December 27, 2022
    Assignee: Harrow IP, LLC
    Inventors: Dennis Elias Saadeh, Mark L. Baum
  • Adrenocorticotropic hormone-based pharmaceutical formulations and methods for fabricating and using thereof
    Patent number: 11338018
    Abstract: Pharmaceutical compositions for treating, mitigating or preventing autoimmune diseases and associated conditions are described herein. Methods for fabricating the compositions and using them are also described.
    Type: Grant
    Filed: January 17, 2019
    Date of Patent: May 24, 2022
    Assignee: Harrow IP, LLC
    Inventors: Dennis Elias Saadeh, Mark L. Baum
  • Pharmaceutical formulations for the treatment of dry eye and methods for fabricating and using thereof
    Patent number: 11185546
    Abstract: Methods and kits for improving tear production are described, along with topical pharmaceutical compositions. In certain instances, the composition comprises pentoxifylline and a pharmaceutically acceptable carrier. The compositions also may further comprise another active agent, such as an anti-bacterial agent, antiviral agent, antifungal agent, or immunosuppressant agent, and combinations thereof.
    Type: Grant
    Filed: May 11, 2020
    Date of Patent: November 30, 2021
    Assignee: Harrow IP, LLC
    Inventors: John Scott Karolchyk, John P. Saharek
  • Epinephrine-based ophthalmic compositions for intraocular administration and methods for fabricating thereof
    Patent number: 11045432
    Abstract: Pharmaceutical compositions for intraocular injection are described, the compositions comprise therapeutically effective quantity of lyophilized preservative-free and sulfite-free epinephrine or adrenaline and a metal chelator. Methods for fabricating the compositions and using them for intraocular injections are also described.
    Type: Grant
    Filed: August 25, 2016
    Date of Patent: June 29, 2021
    Assignee: Harrow IP, LLC
    Inventors: John Scott Karolchyk, Mark L. Baum
  • Pharmaceutical formulations for the treatment of dry eye and methods for fabricating and using thereof
    Patent number: 10695351
    Abstract: Methods and kits for improving tear production are described, along with topical pharmaceutical compositions. In certain instances the composition comprises pentoxifylline and a pharmaceutically acceptable carrier. The compositions also may further comprise another active agent, such as an anti-bacterial agent, antiviral agent, antifungal agent, or immunosuppressant agent, and combinations thereof.
    Type: Grant
    Filed: July 26, 2019
    Date of Patent: June 30, 2020
    Assignee: Harrow IP, LLC
    Inventors: John Scott Karolchyk, John P. Saharek
  • Pyrimethamine-based pharmaceutical compositions and methods for fabricating thereof
    Patent number: 10660891
    Abstract: Pharmaceutical compositions that include aqueous suspensions of a therapeutically effective quantity of a diaminopyrimidine compound (such as pyrimethamine) are provided herein. Methods for fabricating the compositions and using them are also described.
    Type: Grant
    Filed: June 6, 2019
    Date of Patent: May 26, 2020
    Assignee: Harrow IP, LLC
    Inventors: Dennis Elias Saadeh, Annette Marleau, Thomas Ichim
  • PHARMACEUTICAL COMPOSITIONS FOR PREVENTION OR TREATMENT OF CYTOKINE RELEASE SYNDROME
    Publication number: 20200101076
    Abstract: Pharmaceutical compositions and methods for preventing, treating, or alleviating cytokine release syndrome are described, the compositions comprising pentoxifylline and a pharmaceutically acceptable carrier. Methods for using such compositions are also described.
    Type: Application
    Filed: September 25, 2019
    Publication date: April 2, 2020
    Applicant: Harrow IP, LLC
    Inventors: Annette Marleau, Thomas Ichim, Dennis Elias Saadeh
  • Pharmaceutical compositions comprising gels and methods for fabricating thereof
    Patent number: 10561607
    Abstract: Pharmaceutical compositions are described, the compositions comprising a therapeutically effective quantity of an active component and a quantity of a sterile gel. Methods for fabricating the compositions and using them for ophthalmic or burn-treating applications are also described.
    Type: Grant
    Filed: December 30, 2016
    Date of Patent: February 18, 2020
    Assignee: Harrow IP, LLC
    Inventor: John Scott Karolchyk
  • Pharmaceutical formulations of xanthine or xanthine derivatives, and their use
    Patent number: 10383875
    Abstract: The present invention relates to pharmaceutical formulations comprising xanthine or xanthine derivatives, kits thereof, and methods for treating fibrotic diseases by local administration.
    Type: Grant
    Filed: June 12, 2017
    Date of Patent: August 20, 2019
    Assignee: HARROW IP, LLC
    Inventors: Matthew J. Buderer, Dennis Saadeh, Andrew R. Boll